Skip to main content
. Author manuscript; available in PMC: 2012 Oct 24.
Published in final edited form as: Biochem Pharmacol. 2011 Feb 15;81(8):1036–1042. doi: 10.1016/j.bcp.2011.01.025

Table 3.

Genes regulated by both low dose and high dose risedronate with 24 hr treatment.

10−8M 10−4M
Symbol Description Fold P value Fold P value
Signaling Array
Hk2 Hexokinase 2 10.1 0.003 2.3 0.02
Fos FBJ murine osteosarcoma viral oncogene homolog 10.1 0.003 12.3 0.002
Fas Fas (TNF receptor superfamily, member 6) 2.9 0.003 2.5 0.004
Cebpb CCAAT/enhancer binding protein (C/EBP), beta 2.4 0.0003 3.1 0.0002
Pparg Peroxisome proliferator activated receptor gamma 2.1 0.006 5.4 0.001
Birc1b Baculoviral IAP repeat-containing 1b 0.4 0.009 0.2 0.003
Osteogenesis Array
Mmp8 Matrix metallopeptidase 8 5.4 0.02 6.5 0.02
Mmp10 Matrix metallopeptidase 10 2.9 0.02 5.2 0.008
Col7a1 Procollagen, type VII, alpha 1 (predicted) 0.4 0.00007 0.3 0.00003
Col6a1 Procollagen, type VI, alpha 1 (predicted) 0.4 0.0008 0.4 0.0009
Tfip11 Tuftelin interacting protein 11 0.3 0.0005 0.5 0.001
Comp Cartilage oligomeric matrix protein 0.2 0.00002 0.1 0.00001
Flt1 FMS-like tyrosine kinase 1, VEGFR1 0.08 0.001 0.09 0.002
Bmpr1a Bone morphogenetic protein receptor, type 1A 0.04 0.006 0.05 0.006